England Unlocks £560m Savings With Generic Dapagliflozin Policy

As NICE Finalizes Access For SGLT-2 & GLP-1s In Diabetes

 
• By Neena Brizmohun
  
Diabetes Type 2 Written On Wooden Blocks
NICE has overhauled type 2 diabetes care (Shutterstock)

More from Policy & Regulation

More from Generics Bulletin